CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.CELZEarnings & Financial Report
The Institute for Creative Technologies (ICT) is a University Affiliated Research Center at the University of Southern California located in Playa Vista, California. ICT was established in 1999 with funding from the US Army.
CELZ Q3 FY2025 Key Financial Metrics
Revenue
$0
Gross Profit
$0
Operating Profit
$-1.3M
Net Profit
$-1.2M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.48
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Q3 FY2025 Financial Summary
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported revenue of $0 for Q3 FY2025, with a net profit of $-1.2M (down 18.8% YoY) (N/A margin). Cost of goods sold was $0, operating expenses totaled $1.3M.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-1.2M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 FY2025 |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Annual Revenue by Year
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. annual revenue history includes year-by-year totals (for example, 2023 revenue was $9.0K).
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Quarterly Revenue & Net Profit History
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $0 | — | $-1.2M | N/A |
| Q2 FY2025 | $0 | — | $-1.2M | N/A |
| Q3 FY2024 | $0 | — | $-1.0M | N/A |
| Q2 FY2024 | $8.0K | — | $-1.6M | -19471.6% |
| Q1 FY2024 | $0 | — | $-1.0M | N/A |
| Q4 FY2023 | $3.0K | -83.9% | N/A | N/A |
| Q3 FY2023 | $6.0K | -89.1% | $-1.5M | -24232.5% |
| Q2 FY2023 | $0 | — | $-1.1M | N/A |
Income Statement
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $6000 | $3000 | $0 | $8000 | $0 | $0 | $0 |
| YoY Growth | N/A | -89.1% | -83.9% | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $14.1M | $12.5M | $10.7M | $9.6M | $8.0M | $6.9M | $7.1M | $5.9M |
| Liabilities | $398527 | $421159 | $371394 | $390959 | $376272 | $330908 | $277644 | $261353 |
| Equity | $13.7M | $12.1M | $10.3M | $9.2M | $7.6M | $6.6M | $6.8M | $5.6M |
Cash Flow
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-986737 | $-1.3M | $-8.0M | $-896864 | $-1.5M | $-985588 | $-1.2M | $-1.2M |